Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.080
+0.010 (0.48%)
At close: Sep 18, 2026, 4:00 PM EDT
2.085
+0.005 (0.24%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $82.25 million as of September 18, 2026. Its market cap has decreased by -32.68% in one year.
Market Cap
82.25M
Enterprise Value
5.00M
1-Year Change
-32.68%
Ranking
Category
Stock Price
$2.08
ChartMarket Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $82.25M, a decrease of -83.15%. That is a compound annual growth rate of -29.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 82.25M | -27.76% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Microbot Medical | 96.72M |
| LENSAR | 93.86M |
| electroCore | 90.61M |
| Hyperfine | 84.97M |
| Pulmonx | 82.03M |
| CVRx, Inc. | 79.92M |
| Outset Medical | 59.02M |
| Rapid Micro Biosystems | 57.68M |